Literature DB >> 24549509

[Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?].

C Meerwein1, D Vital, M Greutmann, C Schmid, G F Huber.   

Abstract

Amiodarone plays a pivotal role in the treatment of ventricular and supraventricular arrhythmias. However, amiodarone-induced hyperthyroidism (AIH) is one of the most feared complications, which necessitates interdisciplinary treatment and careful balancing of the risks of conservative treatment against those of total thyroidectomy. In this article we discuss the pharmacological aspects of amiodarone and its diverse effects on the thyroid. Furthermore, we present diagnostic and therapeutic strategies and report our positive experiences with total thyroidectomy in patients with AIH. Particularly in patients for whom continuation of amiodarone treatment is compulsory, a well-timed total thyroidectomy is a reliable therapeutic option, with minimal complication rates and immediate amelioration of symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549509     DOI: 10.1007/s00106-013-2806-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  29 in total

Review 1.  The effects of amiodarone on the thyroid.

Authors:  E Martino; L Bartalena; F Bogazzi; L E Braverman
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study.

Authors:  Fausto Bogazzi; Luigi Bartalena; Luca Tomisti; Giuseppe Rossi; Sandra Brogioni; Enio Martino
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

3.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.

Authors:  L Bartalena; S Brogioni; L Grasso; F Bogazzi; A Burelli; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 4.  [Pharmacotherapy of hyperthyreosis--adverse drug reactions].

Authors:  Ludwig Perger; Ulrich Bürgi; Karin Fattinger
Journal:  Ther Umsch       Date:  2011-06

5.  Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial.

Authors:  Silvia A Eskes; Erik Endert; Eric Fliers; Ronald B Geskus; Robin P F Dullaart; Thera P Links; Wilmar M Wiersinga
Journal:  J Clin Endocrinol Metab       Date:  2011-11-30       Impact factor: 5.958

6.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; M Lenziardi; L Baschieri; L E Braverman; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

7.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

8.  Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.

Authors:  M D Trip; W Wiersinga; T A Plomp
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965

9.  The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease.

Authors:  Elizabeth N Pearce; Fausto Bogazzi; Enio Martino; Sandra Brogioni; Enia Pardini; Giovanni Pellegrini; Arthur B Parkes; John H Lazarus; Aldo Pinchera; Lewis E Braverman
Journal:  Thyroid       Date:  2003-07       Impact factor: 6.568

10.  Iodine kinetic studies during amiodarone treatment.

Authors:  R H Rao; V R McCready; G S Spathis
Journal:  J Clin Endocrinol Metab       Date:  1986-03       Impact factor: 5.958

View more
  1 in total

1.  Early Timing of Thyroidectomy for Hyperthyroidism in Graves' Disease Improves Biochemical Recovery.

Authors:  Domenic Vital; Grégoire B Morand; Christian Meerwein; Roman D Laske; Hans C Steinert; Christoph Schmid; Michelle L Brown; Gerhard F Huber
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.